SAFETY, TOLERABILITY AND BIOEQUIVALENCE ASSESSMENT OF A DISPERSIBLE TABLET FORMULATION OF PYRAZINAMIDE. Int. J. Pharm. Sci. Drug Res. [Internet]. 2017 Sep. 1 [cited 2025 Oct. 24];9(5):220-3. Available from: https://ijpsdronline.com/index.php/journal/article/view/561